Intuitive Surgical highlights leadership shift, shares trade lower on Nasdaq
22.06.2026 - 20:25:39 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-22, 20:24.
Intuitive Surgical (US46120E6023) has reshaped its commercial leadership, promoting Taylor Patton to Chief Commercial and Marketing Officer, according to an announcement dated June 20. The Nasdaq-100 member continues to trade near the lower end of its 52-week range as recent analyst actions diverge on valuation.
New commercial chief at Intuitive
On June 20, Intuitive Surgical reported that Taylor Patton had been appointed Chief Commercial and Marketing Officer, with responsibility for global commercial strategy and execution. The company emphasized Patton’s prior experience leading U.S. sales and marketing for its flagship robotic platforms in the official IR release of June 20.
The Sunnyvale-based medtech group, whose shares trade on Nasdaq under the ticker ISRG, framed the move as part of a broader focus on commercial efficiency and surgeon adoption. Patton reports directly to Chief Executive Gary Guthart, underscoring the strategic weight of the new role in Intuitive Surgical’s growth agenda.
Analyst targets diverge on ISRG
Analysts remain divided on Intuitive Surgical’s valuation, with a wide range of price targets despite a generally positive long-term view. MarketBeat data point to an average analyst price target near 573 dollars per share and a “Moderate Buy” consensus rating, based on multiple covering houses including major Wall Street firms.MarketBeat consensus overview
The dispersion of views has widened in recent weeks. Intellectia.ai cites a Deutsche Bank update that cut its price target on Intuitive Surgical shares to 366 dollars from 440 dollars while reiterating a Sell rating, contrasting with more optimistic targets above 600 dollars from other brokers.Deutsche Bank stance via Intellectia.ai
All news and analysis on the Intuitive Surgical shares
Key figures, past earnings and further ad hoc news on Intuitive Surgical are available in the dedicated topic section and on the company’s Investor Relations pages.
The product behind the stock
Intuitive Surgical generates most of its revenue with the da Vinci robotic-assisted surgery system, which is used in procedures such as prostatectomies, hysterectomies and colorectal surgeries. The company earns recurring income from instruments, accessories and service contracts tied to each installed system.
Where the stock trades today
The Intuitive Surgical shares (US46120E6023) most recently traded on Nasdaq at around 401 dollars on June 22, 2026, according to delayed quote data, implying a market capitalization in the area of 142 billion dollars.
Key data on the Intuitive Surgical shares
- Company: Intuitive Surgical, Inc.
- ISIN: US46120E6023
- WKN: 888024
- Ticker: ISRG
- Trading venue: NASDAQ
- Price (as of 2026-06-22, 14:55): 401.33 USD
- Market cap: 142.33 billion USD (as of 2026-06-22)
- Sector / industry: Medical Devices / Robotic-assisted surgery
- Index membership: NASDAQ-100, S&P 500
- Next earnings date: not officially scheduled
Disclaimer: This article is for informational purposes only and does not constitute investment advice, a recommendation or an invitation to buy or sell any securities. Data and prices are based on third-party sources believed to be reliable but cannot be guaranteed. Investors should conduct their own research and consider their individual financial situation before making investment decisions.
